Cargando…
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells
Breast cancer stem-like cells (CSCs) are an important therapeutic target as they are purported to be responsible for tumor initiation, maintenance, metastases, and disease recurrence. Interleukin-8 (IL-8) is upregulated in breast cancer compared with normal breast tissue and is associated with poor...
Autores principales: | Singh, Jagdeep K, Simões, Bruno M, Howell, Sacha J, Farnie, Gillian, Clarke, Robert B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978717/ https://www.ncbi.nlm.nih.gov/pubmed/24041156 http://dx.doi.org/10.1186/bcr3436 |
Ejemplares similares
-
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
por: Howell, Sacha J, et al.
Publicado: (2008) -
Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling
por: Eyre, Rachel, et al.
Publicado: (2019) -
The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells
por: Alferez, Denis G., et al.
Publicado: (2018) -
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity
por: Ablett, Matthew P., et al.
Publicado: (2013) -
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
por: Harrison, Hannah, et al.
Publicado: (2013)